Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells

Author:

Gupta Akash,Mehta Rajeshwari,Alimirah Fatouma,Peng Xinjian,Murillo Genoveva,Wiehle Ronald,Mehta Rajendra G.

Funder

Repros Therapeutics, The Woodlands, TX 77380

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference52 articles.

1. Simultaneous targeting of estrogen receptor and HER2 in breast cancer;Azim;Expert Review of Anticancer Therapy,2010

2. Chemoprevention of hormone receptor-negative breast cancer: new approaches needed;Uray;Recent Results in Cancer Research,2011

3. The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2;Prat;Nature Clinical Practice. Oncology,2008

4. Differential effects of raloxifene, Tamoxifen and fulvestrant on a murine mammary carcinoma;Lamb;Breast Cancer Research and Treatment,2003

5. Aromatase inhibitors as adjuvant therapy for postmenopausal patients with early stage breast cancer;Kudachadkar;CA: A Cancer Journal for Clinicians,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3